Navigation Links
Chronic Myeloid Leukemia: Patient Experience Not Well Understood
Date:10/24/2013

Washington, D.C. (PRWEB) October 24, 2013

The Cancer Support Community's Research and Training Institute and The Leukemia & Lymphoma Society (LLS) have joined forces to launch the Cancer Experience Registry: Chronic Myeloid Leukemia. According to LLS's Facts 2013 booklet, there will be 5,920 new cases of chronic myeloid leukemia (CML) diagnosed in the U.S. this year, making it a rare form of cancer. However, thanks to groundbreaking research advances, supported in part by LLS funding, there are now several effective therapies to treat patients with CML, and a growing number of people are living with the disease.

“CML patients are living longer, fuller lives due to treatment advances, but we believe that survivorship comes with an array of physical and psychosocial issues. Patients will tell us more about these issues and their impact through the Cancer Experience Registry,” said Louis DeGennaro, Ph.D., LLS’s chief mission officer.

Called the Cancer Experience Registry, the global project has already collected information on approximately 5200 people who have volunteered to share their cancer journey by answering questions about their experiences. The new CML component of the registry is an effort to learn more about the specific social and emotional needs of this unique group.

“We are excited about partnering with the Cancer Support Community on this important project,” said Clare Karten, senior director, patient engagement for LLS. “Joining forces adds to our understanding about patients’ experiences and gives us the opportunity to work together with patients to affect change that will improve their quality of life.”

According to Joanne Buzaglo, Ph.D., vice president, research and training for the Cancer Support Community, “The partnership between LLS and CSC truly allows us to combine the expertise and reach of each organization, enabling us to apply learning from the registry to solutions that are meaningful for patients and their families.”

Patients who participate in the Cancer Experience Registry: Chronic Myeloid Leukemia will answer a series of questions about their experiences including questions about the patient-medical team dialogue, side effect management, cancer care planning, financial concerns and the emotional and social effects of their cancer experiences. Participants will be able to instantly compare their responses with those of others in the community and get connected to support and resources that meet their interests and needs.

This fourth in a series of cancer specific registries is possible thanks to the generous support of Pfizer Oncology, the Inaugural Sponsor. “Learning the patient’s perspective is critically important,” said Mace Rothenberg, MD, senior vice president, clinical development and medical affairs, Pfizer Oncology. “We are pleased to partner with the Cancer Support Community and LLS on this initiative.”

In addition to people with a diagnosis of Chronic Myeloid Leukemia, the Cancer Support Community encourages all patients touched by any cancer to join the broader Cancer Experience Registry to lend their voice and be connected to additional resources. An annual index of findings from the Cancer Experience Registry, as well as results from each cancer specific registry, will be published to share the research with the cancer community at large.

“We are so pleased to be able to facilitate the transfer of this information from the voice of the patient to interventions that will impact direct clinical care,” said Kim Thiboldeaux, president and CEO of the Cancer Support Community. “We are grateful to those who have selflessly shared their time and stories with us and the broader cancer community, as we all strive to improve the experience of all people touched by cancer.”

Those who have been diagnosed with chronic myeloid leukemia or any type of cancer at any time are invited and encouraged to join the registry by visiting http://www.CancerExperienceRegistry.org or by calling 1-888-793-9355 to request a paper copy of the survey.

About the Cancer Support Community:

The mission of the Cancer Support Community (CSC) is to ensure that all people impacted by cancer are empowered by knowledge, strengthened by action and sustained by community. In 2009, The Wellness Community and Gilda's Club joined forces to become the Cancer Support Community. The combined organization, with more than 50 years of collective experience, provides the highest quality social and emotional support for people impacted by cancer through a network of over 50 licensed affiliates, more than 100 satellite locations and a vibrant online community, touching more than one million people each year.

Backed by evidence that the best cancer care includes social and emotional support, the Cancer Support Community offers these services free of charge to men, women and children with any type or stage of cancer and to their loved ones. As the largest, professionally led nonprofit network of cancer support worldwide, the Cancer Support Community delivers a comprehensive menu of personalized and essential services including support groups, educational workshops, exercise, art and nutrition classes and social activities for the entire family. In 2012, CSC delivered more than $40 million in free services to patients and families. The Cancer Support Community is advancing the innovations that are becoming the standard in complete cancer care. So that no one faces cancer alone®. For more information, please visit http://www.cancersupportcommunity.org.

About The Leukemia & Lymphoma Society:

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit http://www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

# # #

Read the full story at http://www.prweb.com/releases/2013/10/prweb11266440.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022
2. Opioids for chronic pain: Study looks at how patients and their doctors talk about risks
3. Chronic use of prescription painkillers continues following bariatric surgery
4. New Clinical Study Finds that Nutraceutical Deepak Chopra Endorphinate® Provides Effective, Safe Relief for Chronic Anxiety, Depression, Cravings & Pain Hypersensitivity
5. Chronic Wounds and High Risk Surgical Incisions Successfully Treated with Spiracur’s Ultraportable Negative Pressure Wound Therapy System
6. PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
7. Chronic aggressive behavior in boys: Epigenetic sources?
8. Rosacea Control by Forces of Nature Offers Brand-New Solution to Treat Chronic Skin Condition
9. CWRU researchers find what stresses parents with a chronically ill child
10. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
11. Predicting who will have chronic pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman ... law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at ... DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software ... and employees that are both engaging and easy to use. Coming off the ... software company revealed today its plans to roll out new AI-powered self-service enhancements ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients ... With this in mind, SIGVARIS has created a new line of anti-embolism stockings ... rest and provide the benefits of graduated compression when transitioning from recovery to ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
Breaking Medicine Technology: